Clinical TP53 genetic testing is recommended for HER2-positive breast cancer patients aged 35 or younger by Jing Li, Lili Chen, Xuhui Chen, Meng Huang, Wenhui Guo, Minyan Chen, Yuxiang Lin, Yali Wang, Weifeng Cai, Yibin Qiu, Peng He, Qindong Cai, Chuan Wang, Fangmeng Fu

Get full text